#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	772	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1252	32.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	394	396	ACG	48;50;49	A;C;G	48;50;49	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	2804	Escherichia_coli_EF_Tu	1185	1184	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1435	94.2	0	HET	.	.	.	T135C	.	135	135	T	134	134	T	88	T,C	50,34	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	2804	Escherichia_coli_EF_Tu	1185	1184	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1435	94.2	0	HET	.	.	.	T1167A	.	1167	1167	T	1166	1166	T	62	T,A	43,19	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	2804	Escherichia_coli_EF_Tu	1185	1184	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1435	94.2	0	HET	.	.	.	C210T	.	210	210	C	209	209	C	112	C,T	53,58	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	2804	Escherichia_coli_EF_Tu	1185	1184	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1435	94.2	0	HET	.	.	.	T1170A	.	1170	1170	T	1169	1169	T	58	T,A	39,19	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	2804	Escherichia_coli_EF_Tu	1185	1184	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1435	94.2	0	HET	.	.	.	C954T	.	954	954	C	953	953	C	84	C,T	43,41	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1494	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c4.ctg.1	2052	39.0	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1730	1732	AAA	22;22;21	A;A;A	22;22;21	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1542	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1940	42.6	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1252	1254	GAA	57;56;58	G;A;A	57;56;58	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	484	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	1096	23.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.11	142	45.4	0	.	n	.	0	C990G	SNP	990	990	C	39	39	G	38	G	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.11	142	45.4	0	.	n	.	0	T1002A	SNP	1002	1002	T	51	51	A	50	A	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.11	142	45.4	0	.	n	.	0	A1004G	SNP	1004	1004	A	53	53	G	54	G	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.11	142	45.4	0	.	n	.	0	C1011T	SNP	1011	1011	C	60	60	T	55	T	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.11	142	45.4	0	.	n	.	0	C1023A	SNP	1023	1023	C	72	72	A	62	A	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.11	142	45.4	0	.	n	.	0	T1024A	SNP	1024	1024	T	73	73	A	61	A	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.11	142	45.4	0	.	n	.	0	T1041G	SNP	1041	1041	T	90	90	G	77	G	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	142	90.85	Pasteurella_multocida_16S.l15.c4.ctg.11	142	45.4	0	.	n	.	0	A1042T	SNP	1042	1042	A	91	91	T	76	T	75	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	179	G,A	178,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	170	C	170	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	154	C,A	153,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	214	T	213	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	202	C	199	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	147	C	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	152	A	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	149	A	146	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	149	A,T	147,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	139	T	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	140	C	139	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	134	C	133	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	135	A	133	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	125	G	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	125	C	125	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	137	T	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	171	G	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	187	G	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	190	T	190	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	210	T	210	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	197	G	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	169	C	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	165	A	164	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	142	C	140	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	141	C	139	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	57	A	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	54	A	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	55	G	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	51	C	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	115	T	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	128	G	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	62	T	62	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.3	517	183.1	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	246	C	245	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	T50C	SNP	50	50	T	65	65	C	59	C	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	G74A	SNP	74	74	G	89	89	A	20	A	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	G81.	DEL	81	81	G	95	95	A	20	A	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	A83C	SNP	83	83	A	97	97	C	20	C	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	T92G	SNP	92	92	T	106	106	G	19	G	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	C94.	DEL	94	94	C	107	107	T	19	T,C	11,8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	T97C	SNP	97	97	T	110	110	C	21	C	21	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	T128C	SNP	128	128	T	141	141	C	44	C	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	T135A	SNP	135	135	T	148	148	A	50	A	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	G139C	SNP	139	139	G	152	152	C	52	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	T142G	SNP	142	142	T	155	155	G	52	G	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	G159A	SNP	159	159	G	172	172	A	48	A	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	G161T	SNP	161	161	G	174	174	T	48	T	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	T168G	SNP	168	168	T	181	181	G	47	G	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c4.ctg.5	199	59.7	0	.	n	.	0	C170T	SNP	170	170	C	183	183	T	41	T	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	C990G	SNP	990	990	C	40	40	G	26	G	22	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	T1002A	SNP	1002	1002	T	52	52	A	32	A	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	A1003C	SNP	1003	1003	A	53	53	C	32	C	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	G1008C	SNP	1008	1008	G	58	58	C	25	C	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	C1011T	SNP	1011	1011	C	61	61	T	24	T	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	T1012C	SNP	1012	1012	T	62	62	C	25	C	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	C1023A	SNP	1023	1023	C	72	72	A	35	A	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	.1025G	INS	1025	1025	T	75	75	G	37	G,A	36,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	T1041G	SNP	1041	1041	T	91	91	G	58	G	58	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4572	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c4.ctg.8	143	38.4	0	.	n	.	0	A1042T	SNP	1042	1042	A	92	92	T	58	T	58	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1178	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1695	37.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	250	252	CGT	29;32;32	C;G;T	29;32;32	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1178	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1695	37.0	0	.	p	.	0	V30I	NONSYN	88	90	GTC	334	336	ATC	60;58;61	A;T;C	59;56;60	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1178	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1695	37.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1093	1095	GGC	41;41;42	G;G;C	41;41;42	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1700	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2199	41.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	344	346	AGC	22;24;26	A;G;C	22;24;26	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1700	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2199	41.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	746	748	CTA	49;50;50	C;T;A	49;50;50	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1700	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2199	41.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1265	1267	CAA	45;45;46	C;A;A	44;45;46	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1700	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2199	41.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1364	1366	GGT	41;41;41	G;G;T	41;41;41	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1700	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2199	41.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1934	1936	GTT	28;28;27	G;T;T	28;28;27	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	888	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1691	28.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	636	638	GAA	37;36;34	G;A;A	37;36;34	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	888	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1691	28.1	0	.	p	.	0	M185T	NONSYN	553	555	ATG	816	818	ACC	21;21;21	A;C;C	21;21;21	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	888	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1691	28.1	0	.	p	.	0	S225T	NONSYN	673	675	TCC	936	938	ACT	21;21;21	A;C,A;T	21;20,1;21	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	888	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1691	28.1	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1326	1328	ATC	24;25;27	A;T;C	24;25;26	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1222	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1591	41.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3138	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3703	45.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	546	548	ATC	70;71;70	A;T,C;C	69;70,1;70	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3138	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3703	45.5	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2259	2261	AAG	44;46;46	A;A;G	44;46;46	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1184	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1867	34.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	443	445	GTC	19;19;20	G;T;C	19;19;20	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1184	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1867	34.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1184	1186	TGC	49;48;50	T;G;C	49;48;50	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2842	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	48.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	428	428	T	37	T	37	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2842	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	48.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	734	736	GAC	46;46;44	G;A;C	46;46;44	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2842	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	48.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1010	1012	TTA	33;32;32	T;T;A	33;32;32	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2842	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	48.3	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1193	1195	AAT	52;53;51	A;A;T	52;53;51	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2842	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	48.3	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1980	1980	T	59	T	59	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	2842	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	48.3	0	HET	.	.	.	G186A	.	186	186	G	478	478	G	62	G,A	53,8	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	840	acrR_2	648	648	99.54	acrR_2.l6.c30.ctg.1	1301	34.6	1	SNP	p	R45C	0	.	.	133	135	CGC	500	502	CGC	62;63;65	C,T;G;C	61,1;63;65	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	668	acrS	663	663	98.64	acrS.l6.c30.ctg.1	1186	30.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	384	386	TTC	20;19;19	T;T;C	20;19;19	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	668	acrS	663	663	98.64	acrS.l6.c30.ctg.1	1186	30.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	648	650	GGG	46;43;43	G,A;G;G	45,1;43;43	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1062	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1355	41.8	0	.	p	.	0	V136L	NONSYN	406	408	GTT	711	713	CTT	74;72;72	C;T;T	74;72;72	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2516	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3264	41.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2200	2202	GCA	52;52;53	G;C;A	52;52;52	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2516	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3264	41.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2461	2463	ACC	42;42;40	A;C;C	41;41;40	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2516	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3264	41.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2770	2772	GCC	40;40;43	G;C,A;C	40;38,1;42	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1766	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2429	38.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	324	326	GCT	24;26;28	G;C;T	24;26;28	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1766	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2429	38.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	444	446	GAG	20;20;17	G;A;G	20;20;17	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1766	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2429	38.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	480	482	TGC	20;21;23	T;G;C	20;21;23	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1766	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2429	38.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	663	665	GTT	37;37;37	G;T;T	36;37;37	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1766	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2429	38.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	813	815	CAC	33;33;33	C;A;C	33;33;32	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1766	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2429	38.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1098	1100	ATG	51;51;52	A;T;G	51;50;52	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1766	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2429	38.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2094	2096	CGC	38;35;35	C;G;C	38;35;35	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	740	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1404	28.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	1025	1027	ACC	26;25;22	A;C;C	26;25;22	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	740	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1404	28.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1037	1039	TCG	27;28;29	T;C;G	27;28;29	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	726	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1232	31.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1210	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1901	34.1	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1379	1381	AAA	34;34;35	A;A;A	31;33;35	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1210	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1901	34.1	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1391	1393	GAG	29;29;29	G;A;G	28;28;28	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1210	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1901	34.1	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1397	1399	CAC	30;30;30	C;A;C	30;29;28	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1210	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1901	34.1	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1451	1453	GAG	33;34;35	G;A;G	33;34;34	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1332	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1983	36.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	860	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1239	37.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	950	cysB	975	975	99.28	cysB.l15.c30.ctg.1	1575	32.4	0	.	p	.	0	A146T	NONSYN	436	438	GCT	724	726	ACT	43;42;44	A;C;T	43;42;44	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	622	dfrA1_1	474	474	100.0	dfrA1_1.l6.c30.ctg.1	1019	32.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1;dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1106	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1739	33.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	942	944	GTC	55;54;54	G;T;C	55;52;54	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1644	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2161	40.7	0	.	p	.	0	E197K	NONSYN	589	591	GAA	921	923	AAA	54;52;51	A;A;A	54;52;50	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1132	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1747	34.6	0	.	p	.	0	G209S	NONSYN	625	627	GGC	945	947	AGC	34;34;33	A;G;C	32;34;31	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	531	80	emrE_1	333	326	92.33	emrE_1.l15.c17.ctg.1	326	9.6	0	.	p	.	0	I100V	NONSYN	298	300	ATT	291	293	GTC	2;2;2	G;T;C	2;2;2	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	531	80	emrE_1	333	326	92.33	emrE_1.l15.c17.ctg.1	326	9.6	0	.	p	.	0	T108A	NONSYN	322	324	ACA	315	317	GCA	1;1;1	G;C;A	1;1;1	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1108	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1658	35.7	0	.	p	.	0	K176R	NONSYN	526	528	AAG	778	780	AGG	35;35;34	A;G;G	35;35;34	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1108	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1658	35.7	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1168	1170	GAC	34;32;31	G;A;C	34;32;31	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	736	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1191	33.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1828	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2189	44.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	688	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1209	30.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	461	463	CTG	47;47;48	C;T;G,A	47;47;47,1	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	T38I	NONSYN	112	114	ACA	526	528	ATA	22;22;21	A;T;A	22;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	L42V	NONSYN	124	126	CTA	538	540	GTA	24;25;27	G;T;A	24;25;27	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	A93T	NONSYN	277	279	GCG	691	693	ACG	29;29;30	A;C;G	29;29;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	A114E	NONSYN	340	342	GCA	754	756	GAA	28;29;29	G;A;A	28;29;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	T127A	NONSYN	379	381	ACT	793	795	GCT	31;30;31	G;C;T	31;30;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	N133D	NONSYN	397	399	AAT	811	813	GAT	31;32;31	G;A;T	31;32;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	P162S	NONSYN	484	486	CCA	898	900	TCA	25;25;20	T;C;A	25;25;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	1027	1029	CAG	28;29;32	C;A;G	28;29;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1165	1167	GTT	28;27;25	G;T;T	28;27;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1321	1323	GAT	17;18;17	G;A;T	17;18;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1489	1491	AAT	36;36;35	A;A;T	35;36;35	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1510	1512	TTA	21;21;20	T,C;T;A	20,1;21;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1711	1713	AAA	23;23;21	A;A;A	23;23;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2446	2448	CAT	52;52;52	C;A;T	52;52;52	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2500	2502	CAT	22;22;22	C;A;T	21;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2518	2520	AGA	25;26;26	A;G;A	24;25;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2533	2535	AAT	29;30;31	A;A;T	29;30;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2680	2682	TCC	25;24;27	T;C;C	25;24;27	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2845	2847	ATT	35;35;34	A;T;T	35;34;34	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2866	2868	GAT	38;41;42	G;A;T	38;41;42	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2980	2982	GTT	54;55;55	G;T;T	54;55;55	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3224	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4286	40.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3265	3267	CAC	50;50;50	C;A;C	50;50;50	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	900	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1365	35.1	1	SNP	p	P64H	0	.	.	190	192	CCA	416	418	CCA	42;46;48	C;C;A	42;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	900	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1365	35.1	1	SNP	p	P64A	0	.	.	190	192	CCA	416	418	CCA	42;46;48	C;C;A	42;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	900	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1365	35.1	1	SNP	p	P64S	0	.	.	190	192	CCA	416	418	CCA	42;46;48	C;C;A	42;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	900	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1365	35.1	1	SNP	p	P64L	0	.	.	190	192	CCA	416	418	CCA	42;46;48	C;C;A	42;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	900	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1365	35.1	1	SNP	p	P64R	0	.	.	190	192	CCA	416	418	CCA	42;46;48	C;C;A	42;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	722	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1110	34.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	L31V	NONSYN	91	93	CTG	28	30	GTG	2;2;2	G;T;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	D34E	NONSYN	100	102	GAT	37	39	GAG	2;2;2	G;A;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	L46P	NONSYN	136	138	CTG	73	75	CCG	2;2;1	C;C;G	2;2;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	E54D	NONSYN	160	162	GAA	97	99	GAT	5;6;6	G;A;T	5;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	I88M	NONSYN	262	264	ATA	199	201	ATG	6;6;6	A;T;G	6;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	202	204	CCG	6;6;6	C;C;G	6;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	235	237	GAA	3;3;3	G;A;A	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	238	240	TCC	3;3;3	T;C;C	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	241	243	GGG	4;3;3	G;G;G	4;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	265	267	AAT	5;5;5	A;A;T	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	140	gadW	729	666	94.29	gadW.l6.c30.ctg.1	772	9.6	0	.	p	.	0	S234A	NONSYN	700	702	TCG	637	639	GCG	9;9;9	G;C;G	9;9;9	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	702	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1238	30.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	403	405	TTA	30;29;28	T;T;A	30;29;28	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	702	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1238	30.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	481	483	ATT	30;30;27	A;T;T	30;30;27	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	702	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1238	30.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	982	984	GGA	30;27;26	G;G;A	29;27;25	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	702	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1238	30.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	988	990	CCG	25;25;25	C;C;G	24;25;24	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2742	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3430	42.9	1	SNP	p	S83L	1	S83L	NONSYN	247	249	TCG	616	618	TTG	55;54;51	T;T;G	55;53;51	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2742	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3430	42.9	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2401	2403	GAA	52;53;54	G;A;A	52;52;54	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2742	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3430	42.9	1	SNP	p	D87G	0	.	.	259	261	GAC	628	630	GAC	49;49;49	G;A;C	48;48;49	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2742	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3430	42.9	1	SNP	p	D87V	0	.	.	259	261	GAC	628	630	GAC	49;49;49	G;A;C	48;48;49	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2742	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3430	42.9	1	SNP	p	D87H	0	.	.	259	261	GAC	628	630	GAC	49;49;49	G;A;C	48;48;49	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2742	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3430	42.9	1	SNP	p	D87N	0	.	.	259	261	GAC	628	630	GAC	49;49;49	G;A;C	48;48;49	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2742	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3430	42.9	1	SNP	p	D87Y	0	.	.	259	261	GAC	628	630	GAC	49;49;49	G;A;C	48;48;49	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2396	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3054	42.1	1	SNP	p	R136E	0	.	.	406	408	CGC	754	756	CGC	46;44;42	C;G;C	45;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2396	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3054	42.1	1	SNP	p	R136S	0	.	.	406	408	CGC	754	756	CGC	46;44;42	C;G;C	45;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2396	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3054	42.1	1	SNP	p	R136I	0	.	.	406	408	CGC	754	756	CGC	46;44;42	C;G;C	45;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2396	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3054	42.1	1	SNP	p	R136G	0	.	.	406	408	CGC	754	756	CGC	46;44;42	C;G;C	45;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2396	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3054	42.1	1	SNP	p	R136L	0	.	.	406	408	CGC	754	756	CGC	46;44;42	C;G;C	45;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2396	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3054	42.1	1	SNP	p	R136H	0	.	.	406	408	CGC	754	756	CGC	46;44;42	C;G;C	45;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2396	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3054	42.1	1	SNP	p	R136C	0	.	.	406	408	CGC	754	756	CGC	46;44;42	C;G;C	45;43;42	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	694	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1231	30.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	548	550	CCG	53;52;50	C;C;G	53;49;50	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	694	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1231	30.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	701	703	GCC	33;32;31	G;C;C	32;32;30	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1096	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1559	37.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	334	336	TCA	25;25;26	T;C;A	25;25;25	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	552	marA	384	384	99.74	marA.l6.c4.ctg.1	992	29.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	590	592	AGC	23;23;23	A;G;C	23;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	692	694	CAT	11;11;11	C;A;T	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	V45E	0	.	.	133	135	GTG	416	418	GTG	50;47;48	G;T;G	50;46;48	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	I49S	0	.	.	145	147	ATC	428	430	ATC	41;41;39	A;T;C	41;41;39	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	A70T	0	.	.	208	210	GCA	491	493	GCA	41;41;40	G;C;A	41;41;40	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	R73C	0	.	.	217	219	CGT	500	502	CGT	35;34;34	C;G;T	35;34;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	R73S	0	.	.	217	219	CGT	500	502	CGT	35;34;34	C;G;T	35;34;34	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	R77C	0	.	.	229	231	CGC	512	514	CGC	29;30;30	C;G;C	29;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	R77L	0	.	.	229	231	CGC	512	514	CGC	29;30;30	C;G;C	29;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	L78M	0	.	.	232	234	CTG	515	517	CTG	30;30;29	C;T;G	30;29;29	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	R94H	0	.	.	280	282	CGC	563	565	CGC	19;20;20	C;G;C	19;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	R94S	0	.	.	280	282	CGC	563	565	CGC	19;20;20	C;G;C	19;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	354	marR	435	435	97.7	marR.l15.c30.ctg.1	887	20.9	1	SNP	p	V96E	0	.	.	286	288	GTA	569	571	GTA	16;17;17	G;T;A	16;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	S7F	NONSYN	19	21	TCC	256	258	TTC	15;14;14	T;T;C	15;14;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	R36I	NONSYN	106	108	AGG	343	345	ATC	22;23;22	A;T;C	22;23;22	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	E42A	NONSYN	124	126	GAA	361	363	GCC	7;7;7	G;C;C	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	N43V	NONSYN	127	129	AAT	364	366	GTG	7;7;7	G;T;G	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	E52D	NONSYN	154	156	GAG	391	393	GAT	16;16;16	G;A;T	16;15;16	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	N59T	NONSYN	175	177	AAC	412	414	ACC	18;18;18	A;C;C	18;18;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	I68L	NONSYN	202	204	ATA	439	441	TTA	19;17;15	T;T;A	19;17;15	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	580	582	CAG	46;47;46	C;A;G	46;47;46	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	D128A	NONSYN	382	384	GAC	619	621	GCC	43;43;44	G;C;C	43;43;44	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	S163A	NONSYN	487	489	TCG	724	726	GCG	54;54;55	G;C;G	53;54;55	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	L231V	NONSYN	691	693	CTT	928	930	GTT	29;29;28	G;T;T	26;27;26	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	1022	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1758	31.1	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1090	1090	C	37	C	37	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	942	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1798	28.1	0	.	p	.	0	V12trunc	TRUNC	34	34	G	322	322	G	45	G	44	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	942	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1798	28.1	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	379	381	CAG	30;29;30	C;A;G	30;29;30	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	942	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1798	28.1	0	.	p	.	0	T83I	NONSYN	247	249	ACC	529	531	ATC	22;21;20	A;T;C	22;21;20	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	942	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1798	28.1	0	.	p	.	0	I99M	NONSYN	295	297	ATA	577	579	ATG	16;16;17	A;T;G	16;16;17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	942	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1798	28.1	0	.	p	.	0	A130T	NONSYN	388	390	GCC	670	672	ACC	19;17;18	A;C;C	19;17;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	942	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1798	28.1	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1051	1053	ACG	41;40;42	A;C;G	41;40;42	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2786	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3628	41.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2057	2059	ACC	43;43;45	A;C;C	43;43;45	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2786	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3628	41.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2450	2452	CAA	44;41;41	C;A;A,G	43;41;39,1	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2786	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3628	41.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2618	2620	ATT	27;27;27	A;T;T	27;27;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2786	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3628	41.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2702	2704	GTT	31;31;34	G;T;T	30;30;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2786	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3628	41.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2810	2812	GAG	34;34;32	G;A;G	34;34;32	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2786	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3628	41.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3038	3040	ATG	31;31;32	A;T;G	29;30;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2786	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3628	41.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3173	3175	GAT	49;47;51	G;A;T	48;45;50	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2606	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3563	39.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	381	383	ATG	20;22;22	A;T;G	19;22;22	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2606	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3563	39.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	867	869	ATC	44;47;46	A;T;C	44;46;46	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2606	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3563	39.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3183	3185	CAC	19;19;19	C;A;C	18;19;18	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2606	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3563	39.2	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3186	3188	CTC	19;18;19	C;T;C	17;17;18	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1446	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1932	40.0	0	.	p	.	0	D3E	NONSYN	7	9	GAT	259	261	GAA	30;30;30	G;A;A	30;30;30	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1446	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1932	40.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	928	930	GCG	49;50;49	G;C;G	49;48;49	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1446	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1932	40.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1270	1272	ATC	38;37;36	A;T;C	38;37;36	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1446	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1932	40.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1573	1575	TTT	58;58;57	T;T;T	58;58;57	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1258	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1675	39.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2952	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3716	42.6	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1143	1145	ACC	40;39;39	A;C;C	40;34;39	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2952	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3716	42.6	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2385	2387	GAC	49;48;47	G;A;C	49;47;47	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1318	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1578	36.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	667	669	ATC	53;54;55	A;T;C	53;54;55	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1318	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	637	19.9	0	.	p	.	0	E5G	NONSYN	13	15	GAA	177	179	GGA	22;22;21	G;G;A	22;22;21	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1114	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1783	33.4	0	.	p	.	0	G134C	NONSYN	400	402	GGT	749	751	TGT	42;42;41	T;G;T	42;42;41	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1114	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1783	33.4	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1319	1321	TTG	50;49;51	T;T;G	49;48;50	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1114	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1783	33.4	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1529	1531	ACG	15;15;13	A;C;G	15;15;13	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1172	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1822	34.3	0	.	p	.	0	A185S	NONSYN	553	555	GCC	863	865	TCC	37;37;35	T;C;C	33;37;34	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	930	mdtN	1032	1032	98.02	mdtN.l15.c4.ctg.1	1499	32.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	583	585	ATT	25;25;27	A;T;T	25;25;27	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	251	253	ATG	32;32;32	A;T;G	30;32;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	317	319	ATC	22;20;22	A;T;C	22;20;22	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	566	568	CGC	31;30;30	C;G;C,G	30;29;28,1	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	932	934	AGC	63;63;63	A;G;C	63;62;62	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1133	1135	GTG	43;42;40	G;T;G	43;42;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1196	1198	AAC	24;25;25	A;A,C;C	22;21,1;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1241	1243	GTC	42;41;41	G;T;C	42;40;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1271	1273	ATA	37;36;35	A;T;A	37;36;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1379	1381	TCT	32;31;33	T;C;T	32;31;32	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1766	1768	GCG	44;44;45	G;C;G	43;44;44	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1908	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2652	38.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1979	1981	ATC	61;59;62	A;T;C	61;59;60	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	S129A	NONSYN	385	387	TCA	637	639	GCG	36;36;35	G;C;G	36;36;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	A187T	NONSYN	559	561	GCC	811	813	ACC	36;36;36	A;C;C	36;36;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	H211R	NONSYN	631	633	CAC	883	885	CGC	55;52;53	C;G;C	55;52;53	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1000	1002	GCT	44;44;46	G;C;T	43;44;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1084	1086	AAA	27;27;26	A;A;A	27;27;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1102	1104	CGA	25;26;27	C;G;A	25;26;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1267	1269	GCC	28;28;27	G;C;C	28;28;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1279	1281	GAT	29;31;30	G;A;T	29;31;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1180	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1944	32.6	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1696	1698	GCT	26;26;24	G;C;T	26;26;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3380	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	4124	44.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1638	1640	AAG	33;32;32	A;A;G	33;32;32	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3380	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	4124	44.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2715	2717	CTG	42;42;42	C;T;G	42;41;42	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	292	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	804	19.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1744	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2301	40.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1068	1070	AAC	45;44;44	A;A;C	45;43;44	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1744	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2301	40.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1614	1616	ATA	56;55;55	A;T;A	56;55;54	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1204	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1816	35.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1428	1430	GAT	47;47;46	G,C;A;T	46,1;47;46	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1204	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1816	35.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1431	1433	CTG	44;44;41	C;T,G;G	44;43,1;40	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	870	nfsA	723	379	98.94	nfsA.l6.c30.ctg.1	874	26.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	316	318	TGT	29;29;26	T;G;T	29;29;26	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	870	nfsA	723	379	98.94	nfsA.l6.c30.ctg.1	874	26.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	586	588	ACC	51;52;52	A;C,G;C	49;51,1;52	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	870	nfsA	723	379	98.94	nfsA.l6.c30.ctg.1	874	26.5	1	SNP	p	R15C	0	.	.	43	45	CGC	280	282	CGC	48;48;46	C;G;C	48;48;46	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	870	nfsA	723	379	98.94	nfsA.l6.c30.ctg.1	874	26.5	1	SNP	p	S33R	0	.	.	97	99	AGC	334	336	AGC	34;33;33	A;G;C	33;33;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	870	nfsA	723	353	99.15	nfsA.l6.c30.ctg.2	876	26.1	0	.	p	.	0	G187D	NONSYN	559	561	GGC	458	460	GAC	44;44;44	G;A;C	44;44;44	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	870	nfsA	723	353	99.15	nfsA.l6.c30.ctg.2	876	26.1	1	SNP	p	G131D	0	.	.	391	393	GGC	290	292	GGC	34;33;34	G;G;C	34;33;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	870	nfsA	723	353	99.15	nfsA.l6.c30.ctg.2	876	26.1	1	SNP	p	R203C	0	.	.	607	609	CGT	506	508	CGT	53;54;54	C;G;T	52;53;53	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	870	nfsA	723	353	99.15	nfsA.l6.c30.ctg.2	876	26.1	1	SNP	p	R203L	0	.	.	607	609	CGT	506	508	CGT	53;54;54	C;G;T	52;53;53	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1358	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1493	48.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1081	1083	GAG	56;56;56	G;A;G	56;56;56	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1358	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1493	48.3	1	SNP	p	G141E	0	.	.	421	423	GGT	568	570	GGT	73;73;71	G;G;T,C	73;73;69,1	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1358	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1493	48.3	1	SNP	p	G141D	0	.	.	421	423	GGT	568	570	GGT	73;73;71	G;G;T,C	73;73;69,1	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1358	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1493	48.3	1	SNP	p	R154D	0	.	.	460	462	CGT	607	609	CGT	57;54;53	C;G;T	56;54;53	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1358	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1493	48.3	1	SNP	p	R154A	0	.	.	460	462	CGT	607	609	CGT	57;54;53	C;G;T	56;54;53	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2342	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2808	44.8	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1898	1900	GTG	48;49;47	G;T;G	48;49;46	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2342	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2808	44.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1925	1927	TCG	53;55;54	T;C;G	46;52;51	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2342	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2808	44.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2540	2542	AAC	35;35;35	A;A;C	35;35;35	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2342	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2808	44.8	1	SNP	p	A85T	0	.	.	253	255	GCG	554	556	GCG	57;60;59	G;C;G	54;60;58	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2342	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2808	44.8	1	SNP	p	D111H	0	.	.	331	333	GAT	632	634	GAT	46;47;47	G;A;T	45;47;45	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2342	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2808	44.8	1	SNP	p	S129P	0	.	.	385	387	TCC	686	688	TCC	37;35;35	T;C;C	37;35;35	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1602	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2445	35.2	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1688	1690	AAC	38;38;38	A;A;C	38;38;36	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1602	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2445	35.2	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1697	1699	GAT	38;39;39	G;A;T	38;39;39	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1562	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1845	45.2	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	831	833	CAG	47;47;50	C,T;A;G	46,1;47;50	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1562	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1845	45.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1305	1307	GAT	37;36;36	G;A;T	37;36;36	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	V146F	0	.	.	436	438	GTT	743	745	GTT	58;55;55	G;T;T	58;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1844	1846	CAG	55;56;56	C;A;G	55;56;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1844	1846	CAG	55;56;56	C;A;G	55;56;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1883	1885	CAC	52;52;52	C;A;C	52;52;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1892	1894	CGT	51;50;48	C;G;T	51;50;48	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1892	1894	CGT	51;50;48	C;G;T	51;50;48	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1898	1900	TCC	50;49;47	T;C;C	50;49;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1904	1906	CTC	46;47;45	C;T;C	45;47;45	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1994	1996	ACC	53;53;54	A;C;C	51;53;54	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1997	1999	CCT	55;56;55	C;C;T	55;56;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4660	49.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2366	2368	CGT	44;44;45	C;G;T	43;44;45	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	.	n	.	0	A226G	SNP	226	226	A	335	335	G	398	G	396	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	.	n	.	0	C719T	SNP	719	719	C	828	828	T	353	T,C	162,188	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	1	SNP	n	A794G	0	.	.	794	794	A	903	903	A	386	A	380	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	1	SNP	n	A794T	0	.	.	794	794	A	903	903	A	386	A	380	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	1	SNP	n	G926A	0	.	.	926	926	G	1035	1035	G	355	G	350	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	1	SNP	n	G926T	0	.	.	926	926	G	1035	1035	G	355	G	350	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	1	SNP	n	G926C	0	.	.	926	926	G	1035	1035	G	355	G	350	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	HET	.	.	.	C183T	.	183	183	C	292	292	C	372	C,T	200,166	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	HET	.	.	.	A250T	.	250	250	A	359	359	A	352	A,T	277,73	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	HET	.	.	.	T90C,G	.	90	90	T	199	199	T	362	T,C,G	221,134,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	HET	.	.	.	G474A,T	.	474	474	G	583	583	G	438	G,A,T	324,109,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	HET	.	.	.	A253T	.	253	253	A	362	362	A	355	A,T	277,72	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	HET	.	.	.	C194T	.	194	194	C	303	303	C	405	C,T	315,81	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	HET	.	.	.	A79G	.	79	79	A	188	188	A	346	A,G	213,128	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	999	99.8	rrsB+.l15.c17.ctg.1	1108	372.1	0	HET	.	.	.	T273A,C	.	273	273	T	382	382	T	357	T,A,C	279,75,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.3	518	390.8	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	277	A	270	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.3	518	390.8	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	277	A	270	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.3	518	390.8	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	277	A	270	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	143	100.0	rrsB+.l15.c17.ctg.4	143	110.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	142	95.1	rrsB+.l15.c17.ctg.6	142	75.1	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	138	A	137	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	142	95.1	rrsB+.l15.c17.ctg.6	142	75.1	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	133	C	133	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	142	95.1	rrsB+.l15.c17.ctg.6	142	75.1	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	135	C	135	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	142	95.1	rrsB+.l15.c17.ctg.6	142	75.1	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	130	G	129	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	142	95.1	rrsB+.l15.c17.ctg.6	142	75.1	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	122	G,C,A	120,1,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13062	rrsB+	1542	142	95.1	rrsB+.l15.c17.ctg.6	142	75.1	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	120	T,A	119,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	660	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1016	34.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	592	soxR	465	465	100.0	soxR.l15.c30.ctg.1	932	33.9	1	SNP	p	R20H	0	.	.	58	60	CGC	284	286	CGC	43;44;45	C;G;C	43;44;45	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	592	soxR	465	465	100.0	soxR.l15.c30.ctg.1	932	33.9	1	SNP	p	G121D	0	.	.	361	363	GGT	587	589	GGT	56;54;54	G;G;T	56;54;54	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	456	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	900	26.7	1	SNP	p	A12S	0	.	.	34	36	GCA	300	302	GCA	47;47;49	G;C;A	47;47;48	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	539	6468	APH_3____Ib+	804	804	99.88	APH_3____Ib+.l6.c30.ctg.1	1400	247.6	0	.	p	.	0	P121Q	NONSYN	361	363	CCG	680	682	CAG	356;354;351	C,T;A;G	352,1;351;350	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	6046	APH_6__Id+	837	837	100.0	APH_6__Id+.l6.c4.ctg.1	1561	207.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	5572	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1458	204.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sul2;Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	7704	tetA	1200	1200	100.0	tetA.l6.c30.ctg.1	1786	230.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	4370	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1195	195.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1570	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2145	39.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
